Oracle Runs

Oracle findings and outcome history for Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) (NCT04295538).

Runs

Findings

Latest Run

Apr 6, 2026, 2:57 PM

All Oracle Findings

Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.

NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)

Will the results be positive?

Trial completed per recent updates (Feb 2026), but no public readout, topline results, or efficacy interpretation found in searches across web, ClinicalTrials.gov, AbbVie sites, or news. No sources frame outcomes as positive/negative; evidence incomplete.

Found Apr 6, 2026, 2:57 PMReviewed Apr 6, 2026, 3:00 PM

Web Searchtipranks.comFeb 11, 2026, 12:00 AM

AbbVie Updates Phase 2 Elezanumab Study in Acute Cervical Spinal Cord Injury

Study listed as completed, last update Feb 9, 2026; confirms data lock but no results or efficacy details disclosed.

ClinicalTrialsclinicaltrials.gov

NCT04295538 Safety And Efficacy Study Of Intravenous Administration Of Elezanumab

Status: Completed. No results posted; primary completion est. Jan 2026. No efficacy or safety outcomes summarized.

NO_DECISIONDismissed75% confidenceGrok 4.20 (xAI)

Will the results be positive?

Trial listed as completed with Feb 2026 update on ClinicalTrials.gov; no results posted, no public readout or interpretation of UEMS efficacy found. No sources clearly frame outcome as positive or negative.

Found Apr 6, 2026, 2:12 PMReviewed Apr 6, 2026, 2:19 PM

Web Searchclinicaltrials.gov

NCT04295538 | Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab...

Completed. Primary endpoint UEMS change at 52 weeks; no results posted or outcome interpretation available.

Web Searchtheglobeandmail.comFeb 12, 2026, 12:00 AM

AbbVie Updates Phase 2 Elezanumab Study in Acute Cervical Spinal Cord Injury: What Investors Should Watch

Trial now completed with data lock signaled by Feb 2026 update; no efficacy results, UEMS findings, or positive/negative framing reported.

NO_DECISIONDismissed80% confidencemanual-chat-review

Will the results be positive?

ClinicalTrials.gov lists this study as completed but without posted results, so there is no clear public trial-specific basis yet to call the readout positive or negative.

Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:32 PM

ClinicalTrialsclinicaltrials.govFeb 11, 2026, 12:00 AM

Study Details | NCT04295538 | ClinicalTrials.gov

ClinicalTrials.gov lists completed; primary completion 2026-01-26; hasResults=false on the latest posted update.

NO_DECISIONDismissed93% confidenceGPT-5.4 (OpenAI)

Will the results be positive?

No clear trial-specific public efficacy readout was found. ClinicalTrials.gov lists NCT04295538 as completed, but recent secondary sources still describe it as ongoing/with no results posted, and AbbVie’s pipeline materials list the asset without a disclosed ELASCI data readout. Evidence is therefore incomplete, not positive or negative.

Found Apr 1, 2026, 6:40 PMReviewed Apr 1, 2026, 6:46 PM

ClinicalTrialsclinicaltrials.govJul 1, 2025, 12:00 AM

Study Details | NCT04295538 | Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab... | ClinicalTrials.gov

ClinicalTrials.gov study record for NCT04295538; the trial is listed as completed, but the surfaced record does not provide a trial-specific efficacy interpretation/readout.

Web Searchpmc.ncbi.nlm.nih.govNov 1, 2025, 12:00 AM

Potential Pharmacologic Treatments in Spinal Cord Injury: A Narrative Review

Review table lists ELASCI / NCT04295538 and notes “N/A (no results posted),” indicating no public trial results were available at that time.

Sponsorinvestors.abbvie.comJan 31, 2025, 12:00 AM

AbbVie Pipeline Update

AbbVie’s pipeline includes “Elezanumab (RGMa) Spinal Cord Injury,” but the anticipated 2025–2026 data-readout list does not identify an ELASCI trial readout.

Outcome History

Public history of accepted oracle reviews and recorded outcome changes for this trial.

No oracle outcome history is available for this trial yet.